| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/05/2006 | US20060003049 Fish feed |
| 01/05/2006 | US20060002937 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 01/05/2006 | US20060002931 Antibodies of angiogenesis inhibiting domains CD148 |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1611785A1 Cloning of transgenic ungulate animals comprising artificial chromosomes |
| 01/04/2006 | EP1402438A4 Pet food kiosk |
| 01/04/2006 | EP1313851B1 Methods and reagents for molecular cloning |
| 01/04/2006 | EP1005542B1 APOLIPOPROTEIN E TRANSGENIC mice AND ASSAY METHODS |
| 01/04/2006 | EP0992189B1 Animals carrying 25-hydroxylated vitamin d3-24-hydroxylase gene transferred thereinto |
| 01/04/2006 | CN2749272Y Feeding shed of field silkworm |
| 01/04/2006 | CN1715401A Method for breeding herd bull |
| 01/04/2006 | CN1234871C Construction method using detoxiase gene as stable expression system in silkworm |
| 01/03/2006 | US6982362 for diagnosis/treatment of arteriosclerosis, diabetes; stem cells |
| 01/03/2006 | US6982361 Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal |
| 01/03/2006 | US6982172 Oocyte vitrification technique |
| 12/29/2005 | WO2005123962A2 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles |
| 12/29/2005 | WO2005123918A1 Expression vector capable of regulating the induction of foreign gene expression |
| 12/29/2005 | WO2005123900A1 Medium and methods for culturing of avian primordial germ cells |
| 12/29/2005 | WO2005103229A3 Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using |
| 12/29/2005 | WO2005049790A3 Skn-1 and gsk-3 genes and proteins |
| 12/29/2005 | WO2004015073A3 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 12/29/2005 | WO2003088924A3 Phosphoinositide 3-kinase mediated inhibition of gpcrs |
| 12/29/2005 | US20050289661 CXCR6 chemokine receptor gene disruptions, and compositions and methods related thereto |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289659 Cre-lox based method for conditional RNA interference |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050287636 Polypeptide; low density lipoprotein antioxidant, efficient delivery of cholesterol to hepatocytes |
| 12/29/2005 | US20050287635 RTD receptor |
| 12/29/2005 | US20050287581 Gene sequence of alpha(1,3)galactosyltransferase |
| 12/29/2005 | US20050287072 Administering a conjugate of a biocompatible entity and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection |
| 12/29/2005 | CA2570086A1 Medium and methods for culturing of avian primordial germ cells |
| 12/28/2005 | EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP) |
| 12/28/2005 | EP1609862A1 Diabetes-mediating proteins and therapeutic uses thereof |
| 12/28/2005 | EP1608962A2 Model for neurodegenerative disorders |
| 12/28/2005 | EP1608743A2 Phosphodiesterase 10a7 isoforms and methods of use |
| 12/28/2005 | EP1608679A1 Dystrophin-related protein (drop1), a marker for carcinomas |
| 12/28/2005 | EP1608396A2 Use of soluble cd14 for treatment of diseases |
| 12/28/2005 | EP1608219A2 Integrase mediated avian transgenesis |
| 12/28/2005 | EP1487259B1 A vocal connection system between humans and animals |
| 12/28/2005 | EP0672159B1 Homologous sequence targeting in eukaryotic cells |
| 12/28/2005 | CN2747874Y High density non-soil scorpion nourishing nest |
| 12/28/2005 | CN1711833A Hatching control of silkworm eggs |
| 12/27/2005 | US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents |
| 12/22/2005 | WO2005121324A1 Es cell mutation method and system |
| 12/22/2005 | WO2005120583A2 Method for preventing or treating cardiac hypertrophy |
| 12/22/2005 | WO2005120547A1 Use of neuregulin-3 for inducing mammary cell differentiation and for the treatment of breast cancer |
| 12/22/2005 | WO2005120222A2 Genetically modified non-human mammals and cells |
| 12/22/2005 | WO2005101956A3 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses |
| 12/22/2005 | WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses |
| 12/22/2005 | WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits |
| 12/22/2005 | WO2004041160A3 Methods and animal model for analyzing age-related macular degeneration |
| 12/22/2005 | US20050283847 Inhibition of gene expression using polynucleotide analogues |
| 12/22/2005 | US20050283845 Method for producing non-human mammal having RNAi phenotype |
| 12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/22/2005 | US20050283843 Novel nuclear transfer technique through the processes of enucleation after activation to produce cloned mammals |
| 12/22/2005 | US20050283842 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 12/22/2005 | US20050283841 Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure |
| 12/22/2005 | US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 12/22/2005 | US20050282764 Method of identifying nucleic acid compositions for muting expression of a gene |
| 12/22/2005 | US20050282273 Medium and methods for culturing of avian primordial germ cells |
| 12/22/2005 | US20050282184 Methods and reagents for molecular cloning |
| 12/22/2005 | US20050282169 Signatory sequences |
| 12/22/2005 | US20050282147 Methods for assaying gene imprinting and methylated CpG islands |
| 12/22/2005 | US20050281812 Antibodies to insulin-like growth factor I receptor |
| 12/22/2005 | US20050281744 Method for assessing the effect of a drug on long term memory formation |
| 12/21/2005 | EP1606419A1 Systems and methods for improving protein and milk production of dairy herds |
| 12/21/2005 | EP1606410A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 12/21/2005 | EP1606198A2 Conditioning of useful insects or mites, method for production thereof and use thereof in the biological eradication of plant ravagers |
| 12/21/2005 | EP1605978A2 Therapeutic compositions |
| 12/21/2005 | EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 12/21/2005 | EP1337650A4 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 12/21/2005 | EP1004238B1 Transgenic pigs |
| 12/21/2005 | CN1711281A Use of EDG2 receptor in an animal model of heart failure |
| 12/21/2005 | CN1709049A Frog artificial breeding and rearing method |
| 12/20/2005 | US6977158 Mammalian IAP gene family, primers, probes, and detection methods |
| 12/15/2005 | WO2005118790A2 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins |
| 12/15/2005 | WO2005118789A2 Therapeutic delivery of adenosine into a tissue |
| 12/15/2005 | WO2005117577A2 Model for neurodegenerative disorders |
| 12/15/2005 | WO2005117576A2 Modification of sugar metabolic process in transgenic cells, tissues and animals |
| 12/15/2005 | WO2005117575A1 A method of disrupting heme transport in nematodes and of modelling and evaluating eukaryotic heme transport |
| 12/15/2005 | WO2005117566A1 Apparatus for producing food with low deuterium concentration |
| 12/15/2005 | WO2005083126A3 Alterations of fibulin genes in macular degeneration |
| 12/15/2005 | WO2005077093A3 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof |
| 12/15/2005 | WO2004089072A9 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 12/15/2005 | WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 12/15/2005 | US20050278798 Method of breeding laboratory animals to optimize tumor suppression and tissue repair functions in vivo and improved methods for conducting experiments and safety testing |
| 12/15/2005 | US20050278797 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals |
| 12/15/2005 | US20050278796 FIAT nucleic acids and proteins and uses thereof |
| 12/15/2005 | US20050278795 Stearoyl-CoA desaturase 4 gene |
| 12/15/2005 | US20050277167 Prolyl 3-hydroxylases |
| 12/15/2005 | US20050276804 Method for preventing or treating cardiac hypertrophy |
| 12/14/2005 | EP1605062A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 12/14/2005 | EP1604997A1 Human polyclonal antibodies from transgenic nonhuman animals |
| 12/14/2005 | EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 12/14/2005 | EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |